How common is Colon cancer?

['Yoká lokasa oyo']

Maladi ya kanser ya estoma epalangani mingi?

Cancer ya colon, eyebani mpe lokola cancer ya colorectal, ezali moko ya ba cancer oyo eyebani mingi na mokili mobimba.

Na kotalela ebongiseli ya mokili mobimba oyo etalelaka bokɔnɔ ya kanser, kanser ya misɔpɔ ya minene to ya monene ezali kanser ya misato oyo eleki mingi epai ya mibali mpe ya mibale epai ya basi.

Na 2020, bato ya sika pene na milio 1.9 bazwaki kanser ya misɔpɔ na mokili mobimba.

Bokono ya cancer ya colon ekeseni na mikili, na mikili ya bozwi lokola Etats-Unis, Europe, mpe Australie, mpe na mikili ya bobola.

Likama ya kozwa kanser ya colon na Etats-Unis ezali 1 na 23 mpo na mibali mpe 1 na 25 mpo na basi.

Nzokande, na bambula oyo euti koleka, motángo ya bato oyo bazali kozwa kanser ya estoma ezali se kokita, mbala mosusu mpo minganga bazali kosala baekzamɛ mingi mpo na koyeba maladi yango mpe koyeba yango noki.

['Makambo oyo ezali na buku yango']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chow WH, Devesa SS, Blot WJ: Colon cancer incidence: recent trends in the United States. Cancer Causes Control. 1991, 2 (6): 419-25.

Gatta G, Capocaccia R, Berrino F, Ruzza MR, Contiero P: Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol. 2004, 15 (7): 1136-42.

Fengju S, Guanglin W, Kexin C: Incidence of colon cancer in Tianjin, China, 1981-2000. Asia Pac J Public Health. 2005, 17 (1): 22-5.

Lin PY, Fung CY, Chang FP, Huang WS, Chen WC, Wang JY, Chang D: Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. J Med Virol. 2008, 80 (10): 1828-34.

Tang C, Fu S, She D, Zhou J, Su W, Zeng T: Effects of Anesthetics on Proliferation and Apoptosis of Drug-Resistant Human Colon Cancer Cells. Biomed Res Int. 2022, 2022 (): 4080585.

Wolin KY, Patel AV, Campbell PT, Jacobs EJ, McCullough ML, Colditz GA, Gapstur SM: Change in physical activity and colon cancer incidence and mortality. Cancer Epidemiol Biomarkers Prev. 2010, 19 (12): 3000-4.

['Koboya: makambo ya monganga']

['Site oyo ezali kaka mpo na koteya mpe koyebisa bato makambo ya monganga, kasi ezali te mpo na kopesa toli to toli ya monganga.']

['Makambo oyo ezali na site yango esengeli te kosalelama mpo na koyeba maladi to kosalisa yango, mpe baoyo balingi kozwa toli ya monganga basengeli kotuna yango epai ya monganga oyo ayebi mosala yango malamu.']

['Tosengi na yo oyeba ete réseau neuronal oyo epesaka biyano na mituna, ezalaka mpenza malamu te soki ezali na makambo ya mituya. Na ndakisa, motango ya bato oyo bazali na maladi moko boye.']

['Sololá ntango nyonso na monganga to na moto mosusu oyo ayebi kosalisa maladi na yo. Koboya toli ya monganga te to kozela te mpo otángi likambo moko na site oyo. Soki okanisi ete ozali na maladi oyo esengeli kosalisa yo nokinoki, bengá 911 to kende na lopitalo ya pene. Site oyo to ndenge oyo ozali kosalela yango ezali na boyokani te na monganga ná moto oyo azali kosalisa yo.']

["Kozanga ndingisa: droit d'auteur"]

['Mobeko ya Copyright ya Milenere ya 1998, 17 U.S.C. § 512 (DMCA) epesi nzela na bakomi ya mikanda oyo bakanisi ete biloko oyo ezali na Internet ezali kobebisa lotomo na bango na kolanda mibeko ya copyright ya Etats-Unis. ']

['Soki ondimi na motema malamu ete makambo to biloko oyo ezali na site Internet to na ba service na biso ezali kobuka mibeko na yo, yo (to moto oyo azali na mokumba ya kobatela yo) okoki kotindela biso mokanda mpo na kosɛnga ete tólongola makambo to biloko yango to tópekisa yo kokɔta na yango. ']

['Basengeli kotinda bansango na mokanda na nzela ya email (tala na "Kotindelana" mpo na adresse ya email). ']

['Mibeko ya DMCA esengi ete mokanda na yo ya kofunda mbeba ya copyright ezala na makambo oyo elandi: (1) kolimbola mosala oyo ezali na droit ya copyright oyo bazali kofunda ete ebebisami; (2) kolimbola makambo oyo bazali kofunda ete ebebisi mpe makambo oyo ekoki mpo na kosalisa biso na koyeba esika makambo yango ezali; (3) makambo ya kosolola na yo, ata mpe adrɛsi na yo, nimero ya telefone mpe adrɛsi ya e-mail; (4) mokanda oyo okomi ete ondimi na motema malamu ete makambo oyo ozali kofunda ete ebebisami epesami nzela te na nkolo ya droit ya copyright, to na agent na ye, to na mibeko nyonso; ']

['(5) mokanda oyo okomi, oyo okotya sinyatili na yango mpo na komonisa ete makambo oyo okomaki ezali solo mpe ete ozali na lotomo ya kolandela lotomo ya babimisi oyo bazali koloba ete ebebisami; ']

['mpe (6) sinyatili ya moto oyo azali na lotomo ya kosala yango to ya moto oyo azali na lotomo ya kosala na nkombo na ye. ']

['Soki otye makambo nyonso te oyo ezali awa na likolo, yango ekoki kosala ete likambo na yo eumela.']

['Ndenge ya kosolola']

['Tosengi otindela biso email na motuna to likanisi nyonso.']

How common is colon cancer?

Colon cancer, also known as colorectal cancer, is one of the most common types of cancer worldwide.

According to the World Cancer Research Fund International, colorectal cancer is the third most common cancer in men and the second most common cancer in women.

In 2020, there were an estimated 1.9 million new cases of colorectal cancer diagnosed globally.

The incidence of colon cancer varies by region, with higher rates in developed countries such as the United States, Europe, and Australia, and lower rates in developing countries.

The lifetime risk of developing colon cancer in the United States is about 1 in 23 for men and 1 in 25 for women.

However, the overall incidence of colon cancer has been declining in recent years, likely due to increased screening and early detection.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.